Impax Asset Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-134,085
Closed -$14M 208
2017
Q4
$14M Hold
134,085
0.8% 54
2017
Q3
$19.6M Buy
134,085
+10,000
+8% +$1.36M 1.12% 32
2017
Q2
$16.1M Sell
124,085
-293
-0.2% -$35.9K 0.91% 45
2017
Q1
$15.5M Hold
124,378
0.87% 50
2016
Q4
$14.4M Sell
124,378
-55,921
-31% -$6.23M 0.82% 58
2016
Q3
$18.8M Sell
180,299
-3,982
-2% -$431K 1.08% 33
2016
Q2
$18.2M Sell
184,281
-27,000
-13% -$2.79M 1.05% 32
2016
Q1
$21.1M Sell
211,281
-15,011
-7% -$1.55M 1.13% 29
2015
Q4
$27.1M Buy
226,292
+13,497
+6% +$1.56M 1.51% 12
2015
Q3
$23M Sell
212,795
-13,476
-6% -$1.67M 1.37% 21
2015
Q2
$26.2M Sell
226,271
-9,937
-4% -$1.14M 1.4% 14
2015
Q1
$27.2M Sell
236,208
-14,679
-6% -$1.75M 1.49% 13
2014
Q4
$28.1M Sell
250,887
-14,870
-6% -$1.57M 1.66% 13
2014
Q3
$25.2M Buy
265,757
+29,776
+13% +$2.69M 1.63% 16
2014
Q2
$20.3M Buy
235,981
+14,971
+7% +$1.14M 1.28% 26
2014
Q1
$15.4M Sell
221,010
-9,874
-4% -$782K 0.99% 40
2013
Q4
$19.5M Buy
230,884
+40,062
+21% +$3.17M 1.24% 35
2013
Q3
$14.7M Sell
190,822
-2,414
-1% -$169K 0.98% 44
2013
Q2
$11.3M Buy
+193,236
New +$11.6M 0.77% 54

Other funds holding CELG

Impax Asset Management's CELG Position: Q1 2018 in Review

Impax Asset Management sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 134,085 shares — an estimated $14M sold.

Impax Asset Management first reported a position in CELG in Q2 2013 and held it in 19 quarters. The position peaked at $28.1M in Q4 2014. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

  • Impax Asset Management reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
  • Impax Asset Management sold 134,085 Celgene Corp shares in Q1 2018, an estimated $14M.
  • Impax Asset Management first reported a position in Celgene Corp in Q2 2013 and held it in 19 quarters.
  • Impax Asset Management's Celgene Corp position peaked at $28.1M in Q4 2014.
  • 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Impax Asset Management's 13F filing for Q1 2018, filed 14 May 2018.